Key result
Central obesity (waist circumference) was significantly associated with higher incident heart failure risk (HR 1.30; 95% CI 1.05-1.61; P=0.017), with inflammation mediating 26.5% of this effect.
Why the study?
Obesity and systemic inflammation are independently associated with heart failure, but whether inflammatory pathways mediate this relationship remains unclear.
Does systemic inflammation mediate the association between central adiposity and incident heart failure in a community-based cohort?
Cohort (n=1,998)
Does systemic inflammation mediate the association between central adiposity and incident heart failure in a community-based cohort?
Hazard Ratio: 1.3 (95% CI 1.05–1.61)
p-value: p=0.017
Systemic inflammation mediates approximately 26-32% of the risk of incident heart failure attributable to central adiposity, highlighting the potential value of targeting both pathways for heart failure prevention.
hs-CRP may partially mediate central adiposity–HF risk; hypothesis-generating and should not yet change practice.
Background Obesity and systemic inflammation have each been independently associated with an increased risk of heart failure (HF). However, whether inflammatory pathways mediate the association between obesity and the development of heart failure remains unclear. Methods We analyzed data from a community‐based cohort of 1998 participants to evaluate multiple adiposity indicators in relation to incident HF. hs‐CRP (high‐sensitivity C‐reactive protein) was examined as a mediator using causal mediation analysis to quantify the contribution of systemic inflammation. Kaplan–Meier analyses and multivariable Weibull accelerated failure time models were applied to estimate hazard ratios (HRs) for HF occurrence. Results Over a median follow‐up of 6.9 years, individuals with elevated hs‐CRP levels showed significantly lower HF‐free survival (log‐rank P =0.010). In multivariable accelerated failure time models, indicators of central obesity and hs‐CRP—but not BMI—were significantly associated with higher HF risk (eg, waist circumference: HR=1.30 [95% CI: 1.05–1.61], P =0.017; hs‐CRP: HR=1.25 [1.05–1.51], P =0.013). Mediation analysis revealed that hs‐CRP accounted for 26.5% of the effect of waist circumference and 32.4% of the effect of waist‐to‐height ratio on HF risk, with statistically significant indirect effects for both. Conclusions Our findings build upon recent conceptual advances by demonstrating that central obesity contributes to HF largely through inflammation. By quantifying the proportion of HF risk attributable to systemic inflammation, this study reinforces the rationale for prioritizing both anti‐obesity and anti‐inflammatory strategies in HF prevention.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) conducted a cohort in Incident Heart Failure (n=1,998). Central obesity (waist circumference) was evaluated on Incident heart failure (HR 1.30, 95% CI 1.05-1.61, p=0.017). Central obesity (waist circumference) was significantly associated with higher incident heart failure risk (HR 1.30; 95% CI 1.05-1.61; P=0.017), with inflammation mediating 26.5% of this effect.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: